Polypeptides for use in self-assembling protein nanostructures

US11485759B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11485759-B2
Application numberUS-201916427493-A
CountryUS
Kind codeB2
Filing dateMay 31, 2019
Priority dateNov 3, 2014
Publication dateNov 1, 2022
Grant dateNov 1, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Synthetic nanostructures, polypeptides that are useful, for example, in making synthetic nanostructures, and methods for using such synthetic nanostructures are disclosed herein.

First claim

Opening claim text (preview).

We claim: 1. A nanostructure, comprising: (a) a plurality of first assemblies, each first assembly comprising a plurality of identical first polypeptides, wherein the first polypeptides comprise an amino acid sequence that is at least 80% identical to, the amino acid sequence of a polypeptide selected from the group consisting of SEQ ID NOS:1-34 and identical at least at one half of identified interface positions; Name Amino Acid Sequence I53-34A MEGMDPLAVLAESRLLPLLTVRGGEDLAGLATVLELMGVG SEQ ID ALEITLRTEKGLEALKALRKSGLLLGAGTVRSPKEAEAAE NO: 1 EAGAAFLVSPGLLEEVAALAQARGVPYLPGVLTPTEVERA LALGLSALKFFPAEPFQGVRVLRAYAEVFPEVRFLPTGGI KEEHLPHYAALPNLLAVGGSWLLQGDLAAVMKKVKAAKAL LSPQAPG I53-34B MTKKVGIVDITFARVDMAEAAIRTLKALSPNIKIIRKTVP SEQ ID GIKDLPVACKKLLEEEGCDIVMALGMPGKAEKDKVCAHEA NO: 2 SLGLMLAQLMTNKHIIEVFVHEDEAKDDDELDILALVRAI EHAANVYYLLFKPEYLTRMAGKGLRQGREDAGPARE I53-40A MTKKVGIVDTTFARVDMASAAILTLKMESPNIKIIRKTVP SEQ ID GIKDLPVACKKLLEEEGCDIVMALGMPGKAEKDKVCAHEA NO: 3 SLGLMLAQLMTNKHIIEVFVHEDEAKDDAELKILAARRAI EHALNVYYLLFKPEYLTRMAGKGLRQGFEDAGPARE I53-40B MSTINNQLKALKVIPVIAIDNAEDIIPLGKVLAENGLPAA SEQ ID EITFRSSAAVKAIMLLRSAQPEMUGAGTILNGVQALAAKE NO: 4 AGATFVVSPGFNPNTVRACQIIGIDIVPGVNNPSTVEAAL EMGLTTLKFFPAEASGGISMVKSLVGPYGDIRLMPTGGIT PSNIDNYLAIPQVLACGGTWMVDKKLVTNGEWDEIARLTR EIVEQVNP I53-47A MPIFTLNTNIKATDVPSDFLSLTSRLVGLILSKPGSYVAV SEQ ID HINTDQQLSFGGSTNPAAFGTLMSIGGIEPSKNRDHSAVL NO: 5 FDHENAMEGIPKNRMYIHFVNLNGDDVGWNGTTF I53-47B MNQHSHKDYETVRIAVVRARWHADIVDACVEAFEIAMAAI SEQ ID GGDRFAVDVFDVPGAYEIPLHARTFAETGRYGAVLGTAFV NO: 6 VNGGIYRHEFVASAVIDGMMNVQLSTGVPVLSAVLTPHRY RDSAEHHRFFAAHFAVKGVEAARACIEILAAREKIAA I53-50A MKMEELFKKHKIVAVLRANSVEEAIEKAVAVFAGGVHLIE SEQ ID ITFTVPDADTVIKALSVLKEKGAIIGAGTVTSVEQCRKAV NO: 7 ESGAEFIVSPHLDEEISQFCKEKGVFYMPGVMTPTELVKA MKLGHTILKLFPGEVVGPQFVKAMKGPFPNVKFVPTGGVN LDNVCEWFKAGVEAVGVGSALVKGTPDEVREKAKAFVEKI RGCTE I53-50B MNQHSHKDYETVRIAVVRARWHAEIVDACVSAFEAAMADI SEQ ID GGDRFAVDVFDVPGAYEIPLHARTLAETGRYGAVLGTAFV NO: 8 VNGGIYRHEFVASAVIDGMMNVQLSTGVPVLSAVLTPHRY RDSDAHTLLFLALFAVKGMEAARACVEILAAREKIAA I53-51A MFTKSGDDGNTNVINKRVGKDSPLVNFLGDLDELNSFIGF SEQ ID AISKIPWEDMKKDLERVQVELFEIGEDLSTQSSKKKIDES NO: 9 YVLWLLAATAIYRIESGPVKLFVIPGGSEEASVLHVTRSV ARRVERNAVKYTKEEPEINRMIIVYLNRLSSLLFAMALVA NKRRNQSEKIYEIGKSW I53-51B MNQHSHKDYETVRIAVVRARWHADIVDQCVRAFEEAMADA SEQ ID GGDRFAVDVFDVPGAYEIPLHARTLAETGRYGAVLGTAFV NO: 10 VNGGIYRHEFVASAVIDGMMNVQLSTGVPVLSAVLTPHRY RSSREHHEFFREHFMVKGVEAAAACITILAAREKIAA I52-03A MGHTKGPTPQQHDGSALRIGIVHARWNKTIIMPLLIGTIA SEQ ID KLLECGVKASNIVVQSVPGSWELPIAVQRLYSASQLQTPS NO: 11 SGPSLSAGDLLGSSTTDLTALPTTTASSTGPFDALIAIGV EIKGETMFHEYIADSVSHGLMRVQLDTGVPVIFGVLTVLT DDQAKARAGVIEGSHNHGEDWGLAAVEMGVRRRDWAAGKT E I52-03B MYEVDHADVYDLFYLGRGKDYAAEASDIADLVRSRTPEAS SEQ ID SELDVACGTGTHLEMFTKEFGDTAGLELSEDMLTHARKRL NO: 12 PDATLHQGDMRDFQLGRKFSAVVSMFSSVGYEKTVAELGA AVASFAEHLEPGGVVVVEPWWFPETFADGWVSADVVRRDG RTVARVSHSVREGNATRMEVHFTVADPGKGVRHFSDVHLI TLFHQREYEAAFMAAGLRVEYLEGGPSGRGLFVGVPA I52-32A MGMKEKFVLIITHGDFGKGLLSGAEVIIGKQENVHTVGLN SEQ ID LGDNIEKVAKEVMRIIIAKLAEDKEIIIVVDLFGGSPFNI NO: 13 ALEMMKTFDVKVITGINMPMLVELLTSINVYDTTELLENI SKIGKDGIKVIEKSSLKM I52-32B MKYDGSKLRIGILHARWNLEIIAALVAGAIKRLQEFGVKA SEQ ID ENIIIETVPGSFELPYGSKLFVEKQKRLGKPLDAIIPIGV NO: 14 LIKGSTMHFEYICDSTTHQLMKLNFELGIPVIFGVLTCLT DEQAEARAGLIEGKMHNHGEDWGAAAVEMATKFN I52-33A MAVKGLGEVDQKYDGSKLRIGILHARWNRKIILALVAGAV

Assignees

Inventors

Classifications

  • C07K14/00Primary

    Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11485759B2 cover?
Synthetic nanostructures, polypeptides that are useful, for example, in making synthetic nanostructures, and methods for using such synthetic nanostructures are disclosed herein.
Who is the assignee on this patent?
Univ Washington
What technology area does this patent fall under?
Primary CPC classification C07K14/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).